Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice

J Clin Invest. 2000 Dec;106(11):1391-8. doi: 10.1172/JCI10557.

Abstract

While nephrologists often observe reduced hematocrit associated with inhibitors of angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We now report that two strains of ACE knockout mice have a normocytic anemia associated with elevated plasma erythropoietin levels. (51)Cr labeling of red cells showed that the knockout mice have a normal total blood volume but a reduced red cell mass. ACE knockout mice, which lack tissue ACE, are anemic despite having normal renal function. These mice have increased plasma levels of the peptide acetyl-SDKP, a possible stem cell suppressor. However, they also show low plasma levels of angiotensin II. Infusion of angiotensin II for 2 weeks increased hematocrit to near normal levels. These data suggest that angiotensin II facilitates erythropoiesis, a conclusion with implications for the management of chronically ill patients on inhibitors of the renin-angiotensin system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia / blood*
  • Angiotensin II / blood
  • Angiotensin II / pharmacology*
  • Animals
  • Blood Pressure / drug effects
  • Erythrocyte Indices
  • Erythropoiesis / drug effects*
  • Female
  • Genotype
  • Hematocrit
  • Kidney / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Peptidyl-Dipeptidase A / blood
  • Peptidyl-Dipeptidase A / deficiency*
  • Peptidyl-Dipeptidase A / genetics
  • Systole

Substances

  • Angiotensin II
  • Peptidyl-Dipeptidase A